Furthermore, in another study, Zhu et al [22] demonstrated that cancer stem cells in HCC are characterized by the co-expression of CD133 and CD44; these cells also showed preferential expression of some stem cell-associated genes and were more resistant to chemotherapeutic agents due to the up-regulation of several ABC transporters. Here, CD44 is linked to hepatocellular carcinoma.